رجوع
نطاق اليوم
KWD 18.11
KWD 18.94
نطاق 52 أسبوعًا
KWD 7.80
KWD 20.25
حجم التداول
324,276
متوسط 50 يوم / 200 يوم
KWD 17.05
/
KWD 14.56
الإغلاق السابق
KWD 18.41
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -14.8 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | -19.1 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 20.000
+8.8%
Low: KWD 14.000
High: KWD 28.000
ربحية السهم المستقبلية
-KWD 3.030
الإيرادات المقدّرة
0
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
-KWD 2.043
-KWD 2.043 – -KWD 2.043
|
190 M | 6 |
| FY2028 |
-KWD 3.081
-KWD 4.410 – -KWD 2.200
|
64 M | 8 |
| FY2027 |
-KWD 3.141
-KWD 4.073 – -KWD 2.116
|
0 | 8 |
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -74.82M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-19.14%
ROIC-12.54%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio27.93
Interest Coverage0.00
التقييم
P/E Ratio
-14.82
P/B Ratio2.05
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -68.00M |
| ROE | -19.14% | ROA | -11.95% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -74.82M |
| ROIC | -12.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 27.93 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -14.82 | P/B Ratio | 2.05 |
| P/S Ratio | N/A | PEG Ratio | -0.56 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.01B | Enterprise Value | 518.42M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Net Income | -68.00M | -51.99M | -37.85M |
| EPS (Diluted) | -1.25 | -1.00 | -0.73 |
| Gross Profit | 0.0 | 0.0 | 0.0 |
| Operating Income | -82.39M | -39.89M | -37.66M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 569.20M | 233.98M | 6.70M |
| Total Liabilities | 77.32M | 15.47M | 23.98M |
| Shareholders' Equity | 491.88M | 218.51M | -17.28M |
| Total Debt | 738,000.0 | 657,000.0 | 0.0 |
| Cash & Equivalents | 489.71M | 230.44M | 4.16M |
| Current Assets | 502.53M | 231.07M | 4.98M |
| Current Liabilities | 17.99M | 15.09M | 23.90M |